PHARMACY

Vera Begley, wife of former NACDS chairman, dies

BY Alaric DeArment

RICHMOND, Ky. — The wife of former National Association of Chain Drug Stores chairman Robert Begley has died, according to published reports.

In an obituary published last month, the Lexington Herald-Leader, a Kentucky newspaper, reported the death of Vera Begley at the age of 93.

Robert Begley, who died in 1979, founded the Begley Drug Co. and served as NACDS chairman. The Robert B. Begley Award, created in 1980, is named in his honor.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Lilly launches Axiron

BY Alaric DeArment

INDIANAPOLIS — A topical medication for treating low testosterone in men now is available, drug maker Eli Lilly said.

Lilly announced the availability of Axiron (testosterone), a topical solution designed for application under the arm.

The Food and Drug Administration approved Axiron in November, making it the only testosterone replacement therapy applied to the underarm.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

ProStrakan announces U.S. launch of Abstral

BY Alaric DeArment

BEDMINSTER, N.J. — A drug used to treat pain in cancer patients now is available in the United States.

ProStrakan Group announced Monday the launch of Abstral (fentanyl) sublingual tablets. The tablets, which disintegrate rapidly and are placed under the tongue, treat breakthrough pain, common in one-half to two-thirds of people with cancer-related pain.

The drug, an opioid and controlled substance, only is available through a Food and Drug Administration-mandated REMS program. The FDA approved the drug in January.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?